1,383 results on '"Kwong, Raymond Y."'
Search Results
102. 3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy
103. Artificial Intelligence to Extract Endogenous Tissue Characteristics: Has the Future Free From Gadolinium Contrast Arrived?
104. Atrial Functional Mitral Regurgitation
105. CMR in Phenotyping the Arrhythmic Substrate
106. Cardiovascular PET/MR: We need evidence, not hype
107. Risk Stratification by Regadenoson Stress Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease
108. Cardiac Magnetic Resonance Imaging
109. Coronary morphological features in women with non-ST-segment elevation MINOCA and MI-CAD as assessed by optical coherence tomography
110. Comparison of the Use of Downstream Tests After Exercise Treadmill Testing by Cardiologists Versus Noncardiologists
111. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis
112. Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association
113. Abstract 19992: Left Ventricular Entropy and Scar Mass Predict Appropriate Device Therapy and End-Stage Heart Failure Outcome in Non-Ischemic Cardiomyopathy Patients Undergoing Primary Prevention Defibrillator
114. Abstract 15165: Simultaneous MR-Tracking (MRT) and Voltage-Device-Tracking (VDT) -Based Navigation Inside MR Scanners by Removing VDT Gradient-Induced-Voltage (GIV) Artifacts: Facilitating Spatially-Accurate and Workflow-Efficient MR-Guided Electrophysiology Procedures
115. Assessment of Myocardial Viability by Cardiac MRI
116. Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification
117. The Incidence, Pattern, and Prognostic Value of Left Ventricular Myocardial Scar by Late Gadolinium Enhancement in Patients With Atrial Fibrillation
118. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
119. Letter to the Editor in response to ‘Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries’ by Matta et al.
120. Aldosterone and Myocardial Extracellular Matrix Expansion in Type 2 Diabetes Mellitus
121. Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy
122. Additional file 1 of Utilization and impact of cardiovascular magnetic resonance on patient management in heart failure: insights from the SCMR Registry
123. Response by Heydari et al to Letter Regarding Article, “Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial”
124. Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
125. 19 - Cardiovascular Magnetic Resonance Imaging
126. RESTING MYOCARDIAL BLOOD FLOW IS INVERSELY RELATED TO AMYLOID BURDEN IN LIGHT CHAIN CARDIAC AMYLOIDOSIS
127. CARDIAC MR PATTERNS OF ISCHEMIC INJURY AND INFARCTION AND RELATIONSHIP WITH CORONARY CULPRIT LESIONS IN WOMEN WITH MINOCA (MI WITH NON-OBSTRUCTIVE CORONARY ARTERIES)
128. SERUM BIOMARKERS AND AMYLOID BURDEN BY LEFT VENTRICULAR EXTRACELLULAR VOLUME PREDICT ADVERSE OUTCOMES IN LIGHT CHAIN AMYLOIDOSIS
129. Quantitative CMR Perfusion in Patients After CABG
130. Prognostic Value of T1 Mapping and Feature Tracking by Cardiac Magnetic Resonance in Patients With Signs and Symptoms Suspecting Heart Failure and No Clinical Evidence of Coronary Artery Disease
131. Left-Ventricular Mechanical Activation and Aortic-Arch Orientation Recovered from Magneto-Hydrodynamic Voltages Observed in 12-Lead ECGs Obtained Inside MRIs: A Feasibility Study
132. Evaluation of malposition of the branch pulmonary arteries using cardiovascular computed tomography angiography
133. Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation
134. Electrocardiographic Features of Sarcomere Mutation Carriers With and Without Clinically Overt Hypertrophic Cardiomyopathy
135. Reproducibility and its confounders of CMR feature tracking myocardial strain analysis in patients with suspected myocarditis
136. Comparison of Dialysis Unit and Home Blood Pressures: An Observational Cohort Study
137. Myocardial Blood Flow Quantification for Evaluation of Coronary Artery Disease by Positron Emission Tomography, Cardiac Magnetic Resonance Imaging, and Computed Tomography
138. Role of Cardiac MRI in Diabetes
139. Gradient-induced voltages on 12-lead ECGs during high duty-cycle MRI sequences and a method for their removal considering linear and concomitant gradient terms
140. A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing
141. Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA)
142. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity
143. Response by Reynolds et al to Letters Regarding Article, “Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women”
144. Multimodality imaging to distinguish between benign and malignant cardiac masses
145. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging
146. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate Utilization
147. Correction to: Imaging the myocardial ischemic cascade
148. Correction: Corrigendum: Diverse human extracellular RNAs are widely detected in human plasma
149. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy
150. Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.